A Test of Highly Optimized Tolerance Reveals Fragile Cell-Cycle Mechanisms Are Molecular Targets in Clinical Cancer Trials

• Satyaprakash Nayak,

  Affiliation Department of Chemical and Biomolecular Engineering, Cornell University, Ithaca, New York, United States of America

  ⨯
• Saniya Salim,

  Affiliation Department of Biological and Environmental Engineering, Cornell University, Ithaca, New York, United States of America

  ⨯
• Deyan Luan,

  Affiliation Department of Chemical and Biomolecular Engineering, Cornell University, Ithaca, New York, United States of America

  ⨯
• Michael Zai,

  Affiliation Department of Chemical and Biomolecular Engineering, Cornell University, Ithaca, New York, United States of America

  ⨯
• Jeffrey D. Varner

  *To whom correspondence should be addressed. E-mail: jdv27@cornell.edu

  Affiliation Department of Chemical and Biomolecular Engineering, Cornell University, Ithaca, New York, United States of America

  ⨯